Virax Biolabs Group Ltd Weighted Average Fair Value At Measurement Date Share Options Granted
Virax Biolabs Group Ltd (VRAX) had Weighted Average Fair Value At Measurement Date Share Options Granted of $0.67 as of 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Notes
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted · last filed 2025-07-02
- 2025-03-31: Weighted Average Fair Value At Measurement Date Share Options Granted $0.67.
- 2024-03-31: Weighted Average Fair Value At Measurement Date Share Options Granted $5.76.
- 2023-03-31: Weighted Average Fair Value At Measurement Date Share Options Granted $33.60; Weighted Average Fair Value At Measurement Date Share Options Granted as first filed $4.14M.
| Period end | Weighted Average Fair Value At Measurement Date Share Options Granted | Weighted Average Fair Value At Measurement Date Share Options Granted as first filed |
|---|---|---|
| 2025-03-31 | $0.67 20-F · filed 2025-07-02 | |
| 2024-03-31 | $5.76 20-F · filed 2025-07-02 | |
| 2023-03-31 | $33.60 20-F · filed 2024-08-20 | $4.14M 20-F · filed 2023-06-14 |